Publications, Pharmaceutical

In Vitro and In Vivo Assessment of Regional Nasal Deposition using Scintigraphy from a Nasal Spray and a Nasal Powder

There is growing recognition that targeted nasal deposition can help to realize the full potential of the nasal route for systemic and nose-to-brain drug delivery. This article describes an experimental study in which gamma scintigraphy was used to compare regional nasal deposition behavior for a nasal spray and nasal powder, with in vitro and in vivo studies. In vitro studies were carried out with a validated nasal cast (use courtesy of Aptar Pharma/DTF/Univ. of Tours). In vivo data was gathered from six healthy volunteers. Both sets of results indicate higher deposition in the olfactory region with the nasal powder. Agreement between in vitro and in vivo results highlights the potential to accelerate nasal drug development studies using appropriate in vitro test methods and nasal casts.

Download Publication
1 Sep 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About nasal drug delivery expertise

This Might Also Be of Interest

12 Jul 2022

Digital Health and Digital Therapeutics: Where are we heading and why?

Webinars, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
5 Jul 2022

Drug, Device, Digital: Reimagined Healthcare

Webinars, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights, Brand Differentiation

Read More
21 Jun 2022

Nasal Drug Delivery Challenges and Trends Ahead

Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation

Read More
9 Jun 2022

Aptar Pharma discusses digital therapeutics for chronic conditions

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
1 10 11 12 13 14 25
Back To Top